Alessandra Dondi

754 total citations
14 papers, 255 citations indexed

About

Alessandra Dondi is a scholar working on Pathology and Forensic Medicine, Genetics and Oncology. According to data from OpenAlex, Alessandra Dondi has authored 14 papers receiving a total of 255 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pathology and Forensic Medicine, 4 papers in Genetics and 4 papers in Oncology. Recurrent topics in Alessandra Dondi's work include Lymphoma Diagnosis and Treatment (10 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Viral-associated cancers and disorders (4 papers). Alessandra Dondi is often cited by papers focused on Lymphoma Diagnosis and Treatment (10 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Viral-associated cancers and disorders (4 papers). Alessandra Dondi collaborates with scholars based in Italy, Brazil and United States. Alessandra Dondi's co-authors include Massimo Federico, Caterina Stelitano, Angelo Michele Carella, Umberto Vitolo, Stefano Luminari, F. Angrilli, Luigi Rigacci, Francesco Di Raimondo, Stefano Sacchi and Luca Arcaini and has published in prestigious journals such as Journal of Clinical Oncology, Blood and British Journal of Haematology.

In The Last Decade

Alessandra Dondi

13 papers receiving 251 citations

Peers

Countries citing papers authored by Alessandra Dondi

Since Specialization

Citations

This map shows the geographic impact of Alessandra Dondi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alessandra Dondi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alessandra Dondi more than expected).

Fields of papers citing papers by Alessandra Dondi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alessandra Dondi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alessandra Dondi. The network helps show where Alessandra Dondi may publish in the future.

Co-authorship network of co-authors of Alessandra Dondi

This figure shows the co-authorship network connecting the top 25 collaborators of Alessandra Dondi. A scholar is included among the top collaborators of Alessandra Dondi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alessandra Dondi. Alessandra Dondi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	Treatment of Bone Marrow Edema of the Talus with Pulsed Electromagnetic Fields 2015 ·Journal of the American Podiatric Medical Association ·Nicolò Martinelli, Alberto Bianchi, (unknown), Alessandra Dondi, (unknown), Francesco Malerba	11
2	Prognostic roles of absolute monocyte and absolute lymphocyte counts in patients with advanced‐stage follicular lymphoma in the rituximab era: an analysis from theFOLL05 trial of the Fondazione Italiana Linfomi 2015 ·British Journal of Haematology ·Luigi Marcheselli, Alessia Bari, Antonella Anastasia, Barbara Botto, Benedetta Puccini, Alessandra Dondi, Angelo Michele Carella, Isabel Alvarez, Annalisa Chiarenza, Annalisa Arcari, Flavia Salvi, Massimo Federico	15
3	The potential of pralatrexate as a treatment of peripheral T-cell lymphoma 2014 ·Expert Opinion on Investigational Drugs ·Alessandra Dondi, Alessia Bari, Samantha Pozzi, Paola Ferri, Stefano Sacchi	2
4	The use of anthracycline at first‐line compared to alkylating agents or nucleoside analogs improves the outcome of salvage treatments after relapse in follicular lymphoma The REFOLL study by the Fondazione Italiana Linfomi 2014 ·American Journal of Hematology ·Giuseppe Rossi, Luigi Marcheselli, Alessandra Dondi, Chiara Bottelli, Alessandra Tucci, Stefano Luminari, Luca Arcaini, Michele Merli, Alessandro Pulsoni, Carola Boccomini, Benedetta Puccini, (unknown), Giovanni Martinelli, Andrea Rossi, Vittorio Ruggero Zilioli, Valentina Bozzoli, Monica Balzarotti, Silvia Bolis, Maria Giuseppina Cabras, Massimo Federico	4
5	Updated results of the FOLL05 phase III trial from the Fondazione Italiana Linfomi comparing R-CVP, R-CHOP, and R-FM in patients with advanced follicular lymphoma. 2014 ·Journal of Clinical Oncology ·Stefano Luminari, Alessandra Dondi, Luigi Marcheselli, Giuseppe Rossi, Carola Boccomini, Annalisa Chiarenza, Luigi Rigacci, Francesco Merli, (unknown), Alessandro Levis, Andrés J.M. Ferreri, Daniele Vallisa, Maria Christina Cox, Monica Balzarotti, Massimiliano Salati, Massimo Federico	0
6	Conservative treatment of a femoral neck fracture following nail removal 2013 ·Journal of Mid-life Health ·Claudio Legnani, Alessandra Dondi, L. Pietrogrande	4
7	R-CVP Versus R-CHOP Versus R-FM for the Initial Treatment of Patients With Advanced-Stage Follicular Lymphoma: Results of the FOLL05 Trial Conducted by the Fondazione Italiana Linfomi 2013 ·Journal of Clinical Oncology ·Massimo Federico, Stefano Luminari, Alessandra Dondi, Alessandra Tucci, Umberto Vitolo, Luigi Rigacci, Francesco Di Raimondo, Angelo Michele Carella, Alessandro Pulsoni, Francesco Merli, Luca Arcaini, F. Angrilli, Caterina Stelitano, Gianluca Gaïdano, Matteo Dell’Olio, Luigi Marcheselli, Vito Franco, Sara Galimberti, Stefano Sacchi, Maura Brugiatelli	173
8	The Role Of Qualitative FDG-PET Assessment Using The 5 Point Deauville Scale For Postinduction Response Assessment In Patients With Follicular Lymphoma. A Study From The Fondazione Italiana Linfomi (FIL) 2013 ·Blood ·Stefano Luminari, Annibale Versari, Antonella Franceschetto, (unknown), (unknown), Fabrizio Bergesio, Carola Boccomini, Alessandra Tucci, Francesco Merli, Chiara Rusconi, (unknown), Alessandra Dondi, Massimo Federico	1
9	R-CVP versus R-CHOP versus R-FM as first-line therapy for advanced-stage follicular lymphoma: Final results of FOLL05 trial from the Fondazione Italiana Linfomi (FIL) 2012 ·American Journal of Clinical Oncology ·Massimo Federico, Stefano Luminari, Alessandra Dondi, Stefano Sacchi, (unknown), S Pileri, Marco Lombardo, Giuseppe Rossi, Luca Arcaini, Teodoro Chisesi, Mario Petrini, Sara Galimberti, Umberto Vitolo, Francesco Di Raimondo, Luigi Rigacci, Carella Am, F. Angrilli, Roberto Freilone, Andrés J.M. Ferreri, (unknown)	6
10	R-CVP versus R-CHOP versus R-FM as first-line therapy for advanced-stage follicular lymphoma: Final results of FOLL05 trial from the Fondazione Italiana Linfomi (FIL). 2012 ·Journal of Clinical Oncology ·Massimo Federico, Stefano Luminari, Alessandra Dondi, Stefano Sacchi, Vito Franco, Stefano Pileri, Marco Lombardo, Giuseppe Rossi, Luca Arcaini, Teodoro Chisesi, Mario Petrini, Sara Galimberti, Umberto Vitolo, Francesco Di Raimondo, Luigi Rigacci, Angelo Michele Carella, F. Angrilli, Roberto Freilone, Andrés J.M. Ferreri, Maura Brugiatelli	12
11	The Outcome of T-Cell Lymphoma Patients Failing First-Line Treatment: Results of a Population Based-Study From the Modena Cancer Registry 2012 ·Blood ·Irène Biasoli, Marina Cesaretti, Stefano Luminari, Monica Bellei, Alessandra Dondi, Emanuela Anna Pesce, (unknown), Micol Quaresima, (unknown), Massimo Federico	1
12	Single-dose palonosetron for prevention of chemotherapy-induced nausea and vomiting in patients with aggressive non-Hodgkin's lymphoma receiving moderately emetogenic chemotherapy containing steroids: results of a phase II study from the Gruppo Italiano per lo Studio dei Linfomi (GISL) 2010 ·Supportive Care in Cancer ·Nicola Di Renzo, Antonella Montanini, Donato Mannina, Alessandra Dondi, (unknown), Salvatrice Mancuso, Maria Rosaria De Paolis, (unknown), Caterina Stelitano, (unknown), Attilio Olivieri, (unknown), Gabriele Buda, Renato Cantaffa, Massimo Federico	20
13	Long term outcome of patients with localized aggressive non-Hodgkin lymphoma treated with PROMECE-CYTABOM plus involved-field radiation therapy: a study by the Gruppo Italiano Studio Linfomi 2009 ·Leukemia & lymphoma ·Donato Mannina, Stefano Luminari, Alessandra Dondi, Giuseppe Polimeno, Luca Baldini, Caterina Stelitano, Francesco Merli, Matteo Dell’Olio, Paolo G. Gobbi, (unknown), (unknown), Maura Brugiatelli, Massimo Federico	2
14	The Early- and Intermediate-Term Toxicity to Primitive Hematopoietic Progenitor Cells of Three Chemotherapy Regimens for Advanced Hodgkin Lymphoma 2009 ·Clinical Lymphoma & Myeloma ·Paolo G. Gobbi, Vittorio Rosti, Francesco Valentino, Elisa Bonetti, Francesco Merli, Caterina Stelitano, Alessandra Dondi, Giovanni Quarta, (unknown), Massimo Federico	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact